Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Acetaminophen; tramadol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for acetaminophen; tramadol hydrochloride and what is the scope of patent protection?

Acetaminophen; tramadol hydrochloride
is the generic ingredient in two branded drugs marketed by Watson Labs, Janssen Pharms, Aurobindo Pharma Ltd, Micro Labs Ltd India, Mylan, Zydus Pharms Usa Inc, Par Pharm, Atlas Pharms Llc, Apotex Inc, Sun Pharm Inds Inc, and Amneal Pharms, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty-five drug master file entries for acetaminophen; tramadol hydrochloride. Thirty-nine suppliers are listed for this compound.

Summary for Generic Name: acetaminophen; tramadol hydrochloride

Drug Master File Entries: see list65
Suppliers / Packagers: see list39
Clinical Trials: see list1,368
Drug Prices:see low prices
DailyMed Link:acetaminophen; tramadol hydrochloride at DailyMed

Pharmacology for Ingredient: acetaminophen; tramadol hydrochloride

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
acetaminophen; tramadol hydrochloride
TABLET;ORAL076475-001Apr 21, 2005ABRXNoNo► Subscribe► Subscribe
Apotex Inc
acetaminophen; tramadol hydrochloride
TABLET;ORAL078778-001Apr 7, 2014ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Inc
acetaminophen; tramadol hydrochloride
TABLET;ORAL077184-001Dec 16, 2005ABRXNoNo► Subscribe► Subscribe
Watson Labs
acetaminophen; tramadol hydrochloride
TABLET;ORAL076914-001Jul 26, 2006DISCNNoNo► Subscribe► Subscribe
Atlas Pharms Llc
acetaminophen; tramadol hydrochloride
TABLET;ORAL202076-001Mar 30, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus